TG Therapeutics Compagnie réclamée
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. Lire la suite
HR or Marketing? Claim Your Free Employer Account
My compensation package in most cases exceeds the industry average and I'm very happy with compensation and benefits.
Posted 24 days ago
Qu’est-ce qui vous rend le plus heureux au travail?
We all work very well together, we've been together for years and by working together we are exponentially better.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
From the day I started, the Leadership Team has done everything possible to make TG a standout company. The work environment is excellent and they truly care about every employee!
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
We all work very hard, but with our goals in mind. And it's great to see how TG has been hitting it's bench marks year after year - it helps keep everyone's morale up!
Other Employee Reviews for TG Therapeutics
×